Pascal SM, Veiga-da-Cunha M, Gilon P, Van Schaftingen E, Jonas JC. Effects of fructosamine-3-kinase deficiency on function and survival of mouse pancreatic islets after prolonged culture in high glucose or ribose concentrations. Am J Physiol Endocrinol Metab 298: E586 -E596, 2010. First published December 15, 2009 doi:10.1152/ajpendo.00503.2009.-Due to their high glucose permeability, insulin-secreting pancreatic ␤-cells likely undergo strong intracellular protein glycation at high glucose concentrations. They may, however, be partly protected from the glucotoxic alterations of their survival and function by fructosamine-3-kinase (FN3K), a ubiquitous enzyme that initiates deglycation of intracellular proteins. To test that hypothesis, we cultured pancreatic islets from Fn3k-knockout (Fn3k Ϫ/Ϫ ) mice and their wild-type (WT) littermates for 1-3 wk in the presence of 10 or 30 mmol/l glucose (G10 or G30, respectively) and measured protein glycation, apoptosis, preproinsulin gene expression, and Ca 2ϩ and insulin secretory responses to acute glucose stimulation. The more potent glycating agent D-ribose (25 mmol/l) was used as positive control for protein glycation. In WT islets, a 1-wk culture in G30 significantly increased the amount of soluble intracellular protein-bound fructose-ε-lysines and the glucose sensitivity of ␤-cells for changes in Ca 2ϩ and insulin secretion, whereas it decreased the islet insulin content. After 3 wk, culture in G30 also strongly decreased ␤-cell glucose responsiveness and preproinsulin mRNA levels, whereas it increased islet cell apoptosis. Although protein-bound fructose-ε-lysines were more abundant in Fn3k Ϫ/Ϫ vs. WT islets, islet cell survival and function and their glucotoxic alterations were almost identical in both types of islets, except for a lower level of apoptosis in Fn3k Ϫ/Ϫ islets cultured for 3 wk in G30. In comparison, D-ribose (1 wk) similarly decreased preproinsulin expression and ␤-cell glucose responsiveness in both types of islets, whereas it increased apoptosis to a larger extent in Fn3k Ϫ/Ϫ vs. WT islets. We conclude that, despite its ability to reduce the glycation of intracellular islet proteins, FN3K is neither required for the maintenance of ␤-cell survival and function under control conditions nor involved in protection against ␤-cell glucotoxicity. The latter, therefore, occurs independently from the associated increase in the level of intracellular fructose-ε-lysines.
formation of stable ketoamines (e.g., fructosamines and ribulosamines) within proteins. These ketoamines can then be slowly and irreversibly converted to a variety of compounds, including advanced glycation end products (AGEs), which alter the structure and function of various extra-and intracellular proteins (42) . In addition, glycation intermediates and the activation of AGE receptor signaling cascade may increase "reactive oxygen species" production, hence oxidative stress and cell dysfunction (4) . These processes are increased significantly in tissues of diabetic patients, in whom they may contribute to the pathogenesis of microvascular complications such as retinopathy, nephropathy, and neuropathy (2, 15) .
Protein glycation and AGE formation are also increased in insulin-secreting pancreatic ␤-cells exposed to chronic hyperglycemia or cultured in the presence of high glucose or more potent reducing sugars such as fructose and ribose (20, 24, 39) . Based on the deleterious effects of in vitro exposure to extracellular AGEs and on the protective effects of aminoguanidine, an inhibitor of AGE formation, and of N-acetyl-L-cysteine (NAC), a free radical scavenger, it has been suggested that protein glycation and the accumulation of AGEs contribute, via an increase in oxidative stress, to the glucotoxic induction of ␤-cell apoptosis and to the reductions of preproinsulin gene expression and of maximal glucose-stimulated insulin secretion typically observed in type 2 diabetes (20, 24, 27, 27a, 30, 39) . However, these studies did not allow distinguishing between the effects of intracellular and extracellular protein glycation.
Contrary to earlier assumptions, it was recently shown both in vitro and in vivo that intracellular protein glycation can be partly reversed by fructosamine-3-kinase (FN3K) and FN3K-related protein (FN3K-RP), two cytosolic protein repair enzymes that phosphorylate the third carbon of free accessible protein-bound ketoamines (44) . The resulting ketoamines-3-P are unstable, breaking down spontaneously to inorganic phosphate and the respective dicarbonyl compounds (such as 3-deoxyglucosone in the case of fructosamines) with consequent restoration of the original amine residue. Although both FN3K and FN3K-RP phosphorylate several types of ketoamines such as ribulosamines and erythrulosamines (10, 38) , FN3K seems unique in its ability to phosphorylate fructosamines arising from the glycation of protein-bound lysines by glucose or glucose 6-phosphate (6, 7) . As a consequence, Fn3k-knockout (Fn3k Ϫ/Ϫ ) mice displayed a 2.5-fold increase in hemoglobinbound fructosamines and an approximate 1.5-to twofold increase in glycation of other intracellular proteins in erythrocytes as well as in brain, kidney, liver, and skeletal muscle (45) . However, despite this increase in intracellular protein glycation, Fn3k Ϫ/Ϫ mice had no obvious phenotypic alteration under normal husbandry conditions, raising questions about the physiological role of the enzyme. Thus, although FN3K activity is usually considered beneficial to the cell, it has been proposed that the toxicity of the dicarbonyl compounds it produces could cancel out the benefits expected from the recovery of protein function (31) .
Rodent pancreatic ␤-cells, which express the high-capacity glucose transporter GLUT2 (29) , are highly permeable to glucose. Thus they are likely to undergo strong intracellular protein glycation under hyperglycemic conditions. Because these cells develop profound alterations of their gene expression, survival, and function when exposed to high glucose concentrations (18, 36) , they represent a good model to evaluate the possible role of intracellular protein glycation in glucotoxicity (31) . In this study, we used islets from Fn3k Ϫ/Ϫ mice to test whether FN3K deficiency increases the alterations of ␤-cell survival and function during prolonged culture in the presence of high glucose concentrations. D-Ribose, a more potent glycating agent than glucose (5, 7), was used as a positive control for protein glycation.
MATERIALS AND METHODS
Materials. Diazoxide, D-ribose, and keyhole limpet hemocyanin (KLH) were from Sigma (St. Louis, MO). Activated CH Sepharose 4B was from GE Healthcare (Roosendael, The Netherlands). All other reagents were of analytical grade.
Production of anti-hexitol-lysine antibodies. Ten milligrams of KLH was reconstituted in 1 ml of H 2O and dialyzed overnight at 4°C against 1 liter of 10 mmol/l potassium phosphate buffer, pH 6, to remove any contaminating amino compounds. Hexitol-lysine was the product of borohydride reduction of fructoselysine (9) and was prepared by incubating fructoselysine with a 2.5-fold molar excess of NaBH 4 in 50 mmol/l NaOH that was acidified and desalted on a Biogel P2 column as described (13) . Coupling of hexitol-lysine (1 mg dissolved in 0.1 ml of PBS) to KLH and production of antiserum were done as described previously (32) . Briefly, anti-hexitol-lysine IgGs were purified from 15 ml of serum diluted twofold with PBS and gently mixed (90 min at 4°C followed by 30 min at 22°C) with 1 ml of CH-Sepharose 4B resin coupled to hexitol-lysine. To remove unbound proteins, the resin was centrifuged (3 min at 800 g) and washed four consecutive times by gentle mixing with 20 ml of PBS (5 min at 22°C) and finally loaded onto a 1-ml disposable plastic column (Pierce, Rockford, IL). The elution of bound proteins (0.5-ml fractions) was as described by Myint et al. (32) . All fractions were checked by ELISA on BSA, lysozyme, or caseine-hexitol-lysine and, as a negative control, on immunoplates coated with glycated (but not reduced) BSA, lysozyme, or caseine. The antibody-containing fractions were pooled and kept at Ϫ80°C in 20-l aliquots.
Animals. The generation and genotyping of FN3K-deficient (Fn3k Ϫ/Ϫ ) mice have been described previously (45) . Fn3k Ϫ/Ϫ mice and their wild-type (WT) littermates were obtained by breeding heterozygous Fn3k ϩ/Ϫ mice (CD1/129 mixed genetic background). They were housed on a 12:12-h light-dark cycle under standard conditions with water and food ad libitum. As reported previously, the body weight and fed blood glucose levels of Fn3k Ϫ/Ϫ and WT mice were not different (45) . All animal procedures were approved by the local Institutional Committee on Animal Experimentation.
Islet isolation and culture. Islets were isolated from Fn3k Ϫ/Ϫ and WT mice matched for sex and age [from 3 to 12 mo, means Ϯ SD (median) 7.6 Ϯ 2.5 (7.3) mo for WT mice and 7.3 Ϯ 2.3 (7.3) for Fn3k Ϫ/Ϫ mice]. Islets were obtained by collagenase digestion of the pancreas followed by density gradient centrifugation, as described previously (23, 34) . They were then cultured for 1-3 wk at 37°C in the presence of 5% CO2 in serum-free RPMI 1640 medium (Invitrogen, Carlsbad, CA) containing 5 g/l BSA and 10 -30 mmol/l glucose (G10 -G30) or G10 ϩ 25 mmol/l D-ribose. To minimize the slow accumulation of AGEs, ribose-containing RPMI was freshly prepared or kept for Յ1 wk at Ϫ20°C before use.
Preparation of purified ␤-cells. ␤-Cells were purified from islets of mice expressing the enhanced yellow fluorescent protein under the control of the rat insulin promoter, i.e., specifically in ␤-cells (37) . Single cells were obtained by dispersing the islets with trypsin, and a population containing Ͼ99% pure ␤-cells was obtained by sorting the cells with a Beckton-Dickinson FACSVantage SE (excitation: 488 nm, emission: 530 nm; 50-m nozzle, 45 psi, 81 KHz). ␤-Cell enrichment of these preparations was attested by an ϳ90% reduction in glucagon and somatostatin mRNA levels, with comparable insulin mRNA levels in ␤-cells vs. whole islets (data not shown).
Measurement of islet gene mRNA levels. Islet total RNA was extracted and reversed transcribed into cDNA using random hexamers and 200 units of M-MLV Reverse Transcriptase Rnase H Ϫ Point Mutant (Promega, Madison, WI). Real-time PCR was performed with an iCycler iQ Real-Time PCR Detection System (Bio-Rad, Hercules, CA). Primer sequences and reaction conditions are detailed in Table 1 . Gene to Tbp mRNA ratios were then computed as 2
. Measurement of protein-bound fructose-lysine levels in isolated islets. After culture, the islets were rinsed three times with BSA-free RPMI medium containing G10. They were then mechanically disrupted in 50 -90 l of lysis buffer containing 50 mmol/l Tris, pH 8.5, 10% protease inhibitors (Roche Complete protease inhibitor tablets 1697498), 200 U/ml DNAse, and 10 mmol/l MgSO 4. After 15 min of centrifugation at 20,000 g, islet proteins in the supernatant (cytosolic fraction) were quantified by the Bradford method (Bio-Rad). Proteinbound fructose-lysines were reduced to hexitol-lysines by incubating 25-50 g of islet proteins overnight at 4°C in 200 l of a buffer The thermal cycle profile consisted of a 3-min step at 95°C to release DNA polymerase activity followed by 40 cycles of amplification (15-s denaturation step at 95°C, 60-to 90-s annealing step at 60 -64°C, and eventual 15-to 30-s extension step at 80 -84°C). Under these conditions, PCR efficiencies were ϳ0.95-1.0. The Tm of the amplicons was systematically determined at the end of the PCR to check their specificity. Their size corresponded to that expected from published sequences, as determined by agarose gel electrophoresis. *Islet sample cDNA input in 25-l reactions (ng total RNA equivalent).
containing 50 mmol/l Tris, pH 8.5, and 50 mmol/l sodium borohydride freshly prepared in 50 mmol/l NaOH. Proteins were then precipitated with 10% trichloracetic acid, solubilized in 25 l Laemmli-SDS buffer, neutralized with 2 mol/l Tris, pH 8.8, separated by SDS-PAGE (10 -12%), and transferred to a PVDF membrane. After transfer, the gel was stained with Coomassie Brillant Blue G-250 (PageBlue Protein Staining Solution; Fermentas, St. Leon-Rot, Germany). After blocking with 5% nonfat dry milk in phosphate-buffered saline (PBS), the membrane was successively incubated overnight with an anti-hexitol-lysine antibody (1/500 in PBS containing 1% BSA) and for 90 min with a horseradish peroxidase-conjugated anti-rabbit antibody (1/10,000 in 5% nonfat dry milk-PBS containing 0.05% Tween-20). The signal obtained by enhanced chemiluminescence was recorded and analyzed with a Molecular Imager ChemiDoc XRS system (Bio-Rad). To correct for possible variations in the amount of proteins loaded on the gel, the average signal intensity of each lane was divided by the average Coomassie Blue staining intensity of the same lane on the corresponding gel. The computed ratios were then normalized to the mean ratio for all conditions within each experiment before the mean Ϯ SE was calculated for all experiments.
Measurement of islet cell apoptosis. The level of histone-associated DNA fragments in islet cell cytosolic extracts (mono-and oligonucleosomes) was measured using the Cell Death Detection ELISA PLUS kit (Roche Diagnostics, Mannheim, Germany). After culture, batches of 30 -40 islets were lysed in 60 -100 l of lysis buffer, and the cytosolic and nuclear fractions were separated by centrifugation. Mono-and oligonucleosomes present in the cytosolic fraction were measured in duplicates. The mean absorbance of each sample was normalized to that of the positive control provided in the kit and corrected for differences in islet DNA content measured (in the nuclear fraction) by fluorimetry using SYBR Green I (25) . The percentage of apoptotic islet cells was also determined using the in situ cell death detection kit (Roche Diagnostics). Briefly, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) reactions were performed on 4-m-thick sections of paraffin-embedded islets using fluorescein-dUTP. Islet cell nuclei were stained with 0.75 g/ml 4=,6-diamidino-2-phenylindole (DAPI). The percentage of apoptotic cells was determined by manually counting fluorescein-and DAPI-positive nuclei on digital images obtained by fluorescence microscopy (FluoArc mounted on an Axioskop 40 coupled to a HBO 100 camera; Carl Zeiss, New York, NY) under standardized conditions (fluorescein: 450 ms, excitation/emmission 475/540 nm; DAPI: 90 ms, excitation/emmission 350/460 nm).
Measurements of intracellular Ca
2ϩ concentration and insulin secretion. After culture, the islets were perifused at 37°C with a bicarbonate-buffered Krebs solution containing (in mmol/l) NaCl (120), KCl (4.8), CaCl 2 (2.5), MgCl2 (1.2), NaHCO3 (24), 1 g/l BSA (fraction V; Roche, Basel, Switzerland), and various glucose concentrations (0.5-30 mmol/l). When the concentration of KCl was raised to 30 mmol/l, that of NaCl was reduced to 94.8 mmol/l to keep the osmolarity unchanged. This solution was continuously gassed with O 2/CO2 (94/6) to maintain pH at ϳ7.4. The acute glucose-induced changes in intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) were recorded by microspectrofluorimetry in furaPE3-loaded islets while glucosestimulated insulin secretion was measured in 2-min effluent collections from 25-100 perifused islets by RIA, as described previously (34) . After perifusion the islets were disrupted by sonication in TNE (10 mmol/l Tris, 0.2 mmol/l NaCl, 10 mmol/l EDTA), and their insulin and DNA contents were measured (25) .
Statistical analysis. Results are means Ϯ SE for at least three different islet preparations. Statistical significance of differences between groups was assessed by unpaired Student's t-test, one-way ANOVA followed by a test of Newman-Keuls, or two-way ANOVA followed by a test of Bonferroni, as specified. Differences were considered significant if P Ͻ 0.05.
RESULTS

Fn3k and Fn3k-rp gene expression in islets from WT and Fn3k
Ϫ/Ϫ mice. We first ascertained that Fn3k mRNA was expressed in pancreatic islets and ␤-cells from control mice. As shown in Table 2 , Fn3k and Fn3k-rp mRNA levels were similar to those of the housekeeping gene Tbp not only in freshly isolated whole islets but also in highly purified ␤-cells, suggesting that both enzymes may be operative in ␤-cells. We next compared Fn3k and Fn3k-rp mRNA levels in islets from Fn3k Ϫ/Ϫ mice and their WT littermates after a 1-wk culture in the presence of G10. This culture condition was chosen as control because it optimally preserves rodent ␤-cell survival, gene expression, and function (28) . As in fresh islets and purified ␤-cells, Fn3k and Fn3k-rp mRNA levels were similar in cultured WT islets. As expected, Fn3k mRNA was not detected in cultured Fn3k Ϫ/Ϫ islets. In the latter, Fn3k-rp (Table  2) . Thus, Fn3k gene inactivation in mouse islets was not compensated for by an increase in Fn3k-rp gene expression.
Effects of FN3K deficiency on islet protein glycation. To verify whether FN3K is functionally expressed in mouse islets, we developed an anti-hexitol-lysine antibody that recognizes protein-bound hexitol-lysines. This allowed us to compare the level of soluble intracellular protein-bound fructose-ε-lysines in extracts of 1-wk-cultured islet cells. Since fructose-ε-lysines are formed following glycation of lysine residues in proteins by glucose and are the major substrate for FN3K (10, 11, 38) , their level is a good indicator of protein glycation. In WT islets, a 1-wk culture in the presence of G30 instead of G10 induced an approximately fourfold increase in protein-bound fructose-ε-lysines. In FN3K-deficient islets, the rate of protein glycation was ϳ2.5-fold higher than in WT islets after culture in G10 and was increased approximately twofold by culture in G30. As a result, the level of protein glycation after culture in G30 was only slightly higher in Fn3k Ϫ/Ϫ than in WT islets (Fig. 1) .
Effects of FN3K deficiency on ␤-cell function and its alteration by high glucose. To test whether an increase in intracellular protein-bound fructose-ε-lysines alters ␤-cell function, we then measured the glucose-induced changes in [Ca 2ϩ ] i and stimulation of insulin secretion in WT and Fn3k Ϫ/Ϫ islets cultured for 1 or 3 wk under control conditions (G10) or in the presence of G30. After 1-3 wk of culture in G10, WT islets stimulated by stepwise increases in glucose concentration (G0.5 to G7, G15, and G30) displayed an initial decrease in [Ca 2ϩ ] i without changes in insulin secretion in G7, followed by concentration-dependent rises in [Ca 2ϩ ] i and insulin secretion in G15 and G30 that were fully abrogated by diazoxide (Dz), a drug that opens ATP-dependent K ϩ -channels and repolarizes ␤-cells (43) . Subsequent depolarization of the islets with 30 mmol/l extracellular K ϩ (K30) in the presence of Dz and G30 maximally increased [Ca 2ϩ ] i and insulin secretion (Figs. 2, A  and E, and 3, A and E) . These responses were almost identical in islets from Fn3k Ϫ/Ϫ mice (Figs. 2, B and F, and 3 , B and F, and Tables 3 and 4), irrespective of their age (from 3 to 12 mo; data not shown). As reported previously (34), a 1-wk culture in G30 markedly increased the glucose sensitivity of mouse islets upon subsequent glucose stimulation, whereas it only slightly affected their maximal response to G30, as shown by the shift to the left of the glucose concentration-response curves for changes in [Ca 2ϩ ] i and insulin secretion (Fig. 2, C and E, and Tables 3 and  4) . A 1-wk culture in G30 also reduced K30-induced [Ca 2ϩ ] i rise by 30 -35% (with a tendency to reduce insulin secretion by 25-30%) and decreased the islet insulin to DNA content ratio by ϳ30% without affecting preproinsulin mRNA levels (Tables 3-5). Similar changes in ␤-cell function and insulin content were observed in Fn3k Ϫ/Ϫ islets cultured for 1 wk in G30 (Fig. 2, D and F, and Tables 3-5) .
After 3 wk of culture in G30, however, the alterations of glucose-and K30-induced changes in [Ca 2ϩ ] i and insulin secretion in WT islets were much stronger than after 1 wk.
Besides the shift to the left of their glucose concentration response curve, these islets also displayed a surprising reduction in [Ca 2ϩ ] i upon stimulation from G15 to G30 that was observed only rarely after 1 wk of culture and an ϳ70% reduction in K30-induced [Ca 2ϩ ] i rise ( Fig. 3C and Table 3 ). Moreover, their maximal insulin secretion responses to glucose and K30 were reduced by 85-90% compared with islets cultured in G10 (Fig. 3E and Table 4 ), and their insulin to DNA content ratio and preproinsulin mRNA levels were decreased by ϳ40 -55% (Table 5 ). Similar changes in ␤-cell function and insulin expression were observed in islets from Fn3k Ϫ/Ϫ mice (Fig. 3, D and F, and Tables 3-5 ). Thus, 3 wk of culture in G30 instead of G10 still increased the islet sensitivity to glucose but strongly reduced their maximal glucose and K30 responsiveness, irrespective of the presence or absence of FN3K. ]i during the last 2 min in G0.5, the last 6 min in G30/Dz, and the whole period in G7, G15, G30, and G30/K30/Dz. Statistical significance of differences between perifusion conditions was assessed by 2-way ANOVA plus a test of Bonferroni comparing the first 4 perifusion conditions ( *P Ͻ 0.05 for the effect of glucose vs. G0.5) or the last 2 perifusion conditions ( †P Ͻ 0.001 for the effect of G30/K30/Dz vs. G30/Dz) across 4 groups of islets (G10 and G30 or G10 and G10 ϩ 25 mmol/l D-ribose). ‡P Ͻ 0.05 for the effect of culture in G30 or G10 ϩ ribose vs. G10). There were no significant differences between islet strains. Results are means Ϯ SE for the indicated number of experiments (n). In each experiment, illustrated in Figs. 2, E and F, 3, E and F, and 4, E and F, we computed the average rate of insulin secretion during the last 8 min in G0.5, the last 6 min in G30/Dz, and the whole period in G7, G15, G30, and G30/K30/Dz. Statistical significance of differences between perifusion conditions was assessed by 2-way ANOVA plus a test of Bonferroni comparing the first 4 perifusion conditions ( a P Ͻ 0.05 for the effect of glucose vs. G0.5) or the last 2 perifusion conditions ( b P Ͻ 0.001 for the effect of G30/K30/Dz vs. G30/Dz) across 4 groups of islets (G10 and G30 or G10 and G10 ϩ 25 mmol/l D-ribose). #P Ͻ 0.05 for the effect of culture in G30 or G10 ϩ ribose vs. G10; &P Ͻ 0.05 for the effect of strain WT vs. Fn3k Ϫ/Ϫ ; *P Ͻ 0.05 for the effect of culture in G30 vs. G10 during perifusion with G7 (1-way ANOVA ϩ test of Newman-Keuls).
Effects of ribose on ␤-cell function in WT and Fn3k
Ϫ/Ϫ islets. Given the lack of effect of FN3K deficiency on ␤-cell function and insulin gene expression after culture in G10 and G30, we also tested the effect of a 1-wk culture in G10 ϩ 25 mmol/l D-ribose. This reducing sugar, which is an ϳ20-fold more potent glycating agent than glucose (5, 7), is known to markedly decrease preproinsulin gene expression and glucosestimulated insulin secretion while triggering ␤-cell apoptosis in various culture systems (19, 20, 30) . After culture in the presence of ribose, the glucose-induced changes in [Ca 2ϩ ] i in WT islets were similar to those observed after culture in G10, except for the occasional presence of a transient [Ca 2ϩ ] i rise upon stimulation with G7 (in 3/13 WT islets and 6/13 Fn3k Ϫ/Ϫ islets), with consequent lack of mean [Ca 2ϩ ] i reduction but no detectable change in insulin secretion (Fig. 4 and Table 3 ). In contrast, the maximal rate of insulin secretion during perifusion with G30 or G30/K30/Dz was reduced significantly, by ϳ60%, in parallel with an ϳ40% decrease in the islet insulinto-DNA content ratio and preproinsulin mRNA levels (Tables  4 and 5 ). The alterations of ␤-cell function, insulin content, and preproinsulin gene expression induced by culture in the presence of ribose were almost identical in Fn3k Ϫ/Ϫ islets (Fig. 4, 
B, D, and F, and Tables 3-5).
Effects of FN3K deficiency on islet cell survival and its alteration by high glucose or ribose. To further evaluate the effect of FN3K deficiency on the sensitivity of islet cells to the deleterious effects of high glucose and ribose, we next measured apoptosis in WT and Fn3k Ϫ/Ϫ islets cultured for 1-3 wk in G10, G30, or G10 ϩ 25 mmol/l D-ribose. As shown in Fig. 5, A and B, the level of cytosolic histone-associated DNA fragments in WT islets slowly increased during culture in G30, reaching statistical significance after 3 wk. Surprisingly, this increase tended to be lower in Fn3k Ϫ/Ϫ vs. WT islets (P Ͻ 0.05 by 1-way ANOVA ϩ test of Newman-Keuls). In comparison, islet cell DNA fragmentation was already strongly increased after only 1 wk of exposure to ribose, and this increase was two-to threefold higher in FN3K-deficient vs. WT islets (Fig. 5C ). That these changes in DNA fragmentation reflected an increase in islet cell apoptosis was confirmed by measurements of the percentage of TUNELpositive cells after 1 wk of culture in G10, G30, or G10 ϩ 25 mmol/l D-ribose (Supplemental Fig. S1 ; Supplemental Material for this article is available at the AJP-Endocrinology and Metabolism website).
Effects of FN3K deficiency on islet stress response gene expression and their alteration by high glucose or ribose. It has been shown previously that D-ribose exerts its proapoptotic effect in pancreatic ␤-cells through an increase in oxidative stress (20) . In agreement with these studies, we also observed that ribose-induced DNA fragmentation was markedly reduced by addition of NAC to the culture medium, thereby suppressing the difference between FN3K-deficient and WT islets (Supplemental Fig. S2) . In a first attempt to test whether differences in oxidative stress could contribute to the lower or higher rates of apoptosis in FN3K-deficient islets cultured in high glucose or ribose, we measured the mRNA levels of a few stress response genes whose levels change in parallel with the rate of apoptosis in rat islets cultured in the presence of low, intermediate, and high glucose concentrations, i.e., c-Myc, heme oxygenase 1 (Hmox1), and metallothionein 1a (Mt1a) (3). As shown in Fig. 6 , the mRNA levels of the three genes were similar in FN3K-deficient and WT islets cultured for 1 wk in either G10 or G30, in marked contrast with earlier observations in rat islets (12) . The mRNA levels of Mt1a and Hmox1 were also little or not affected by 3 wk of culture in G30. In contrast, c-Myc mRNA levels markedly increased under the latter condition, but to a lesser extent in FN3K-deficient islets. In comparison, the mRNA levels of the three genes were all significantly increased by culture in the presence of D-ribose. Under that condition, Mt1a mRNA levels were ϳ50% lower in Fn3k Ϫ/Ϫ islets, but their relative increase was similar in both types of islets (5.8-fold in WT islets, 6.6-fold in Fn3k Ϫ/Ϫ islets).
DISCUSSION
This study demonstrates that FN3K deficiency increases intracellular glycated ketoamines in pancreatic islets from Fn3k Ϫ/Ϫ mice cultured under control conditions, thereby confirming that FN3K acts as a deglycating enzyme in the endocrine pancreas and that, as in other tissues (45) , its absence cannot be fully compensated for by FN3K-RP enzymatic activity. However, in agreement with the observation that Figs. 2, E and F, 3, E and F, and Fig. 4 , E and F. Ins-to-Tbp mRNA ratios were measured by real-time RT-PCR and normalized to the mean ratio for all conditions within each experiment before being expressed relative to the levels in WT islets cultured in G10. The difference in CT between preproinsulin and Tbp cDNA amplification in WT islets was comparable after 1 and 3 wk of culture in G10 (Ϫ15.9 Ϯ0.5 and Ϫ16.8 Ϯ 0.4). *P Ͻ 0.05 for the effect of culture (G30 or G10 ϩ ribose vs. G10; (2-way ANOVA ϩ test of Bonferroni). There were no significant differences between islet strains. glucose homeostasis is normal in FN3K-deficient mice (45), FN3K deficiency affected neither islet gene expression and cell survival nor ␤-cell responses to acute glucose stimulation after Յ3 wk of culture in G10, a glucose concentration known to optimally preserve ␤-cell function, gene expression, and survival in vitro (3, 16) . Thus, as shown previously in tissues prone to develop diabetic glucotoxic complications, such as the kidney, a two-to threefold increase in intracellular protein-bound fructose-lysines had no detectable impact on islet cell survival and ␤-cell function. Therefore, these results suggest that functional expression of FN3K in cultured islet ␤-cells is dispensable for the maintenance of their function and survival under control conditions either because the lack of repair of intracellular glycated proteins was not harmful within that time frame or because its deleterious effect was cancelled out by a hypothetical beneficial reduction in 3-deoxyglucosone production (31, 33) . However, these results did not exclude the possibility that FN3K activity may protect ␤-cells under stronger glycating conditions, i.e., in the presence of a higher glucose concentration or of the more potent glycating agent D-ribose. In agreement with previous studies carried out in rat pancreatic islets and insulin-secreting cell lines (24, 39) , prolonged culture in the presence of a supraphysiological glucose concentration (G30) increased intracellular protein-bound fructose-lysines in islets from WT mice. Culture in G30 also increased the sensitivity of mouse islets to subsequent acute glucose stimulation after 1 wk and later (between 1 and 3 wk) reduced their glucose and K30 responsiveness, lowered preproinsulin gene expression (mRNA and protein content), and increased islet cell apoptosis and c-Myc mRNA levels. Thus, a long enough culture in G30 induces the typical glucotoxic alterations of islet cell function, survival, and gene expression in mouse as well as in rat islets (3, 23) . These effects of G30 were almost identical in islets from FN3K-deficient mice (even at 12 mo of age), except for the lower induction of islet cell DNA fragmentation and c-Myc mRNA expression. Thus, although the level of protein-bound fructose-ε-lysines was only slightly higher in Fn3k Ϫ/Ϫ vs. WT islets cultured in G30, FN3K deficiency has a detectable impact on pancreatic islets. The reason why FN3K deficiency had a lesser impact in G30 than in G10 is not clear but may be related to the 50% reduction in Fn3k mRNA levels in WT islets cultured in G30 vs. G10 (data not shown) and, as a consequence, the lesser difference in Fn3k expression between WT and Fn3k Ϫ/Ϫ islets. From the data discussed above, we can conclude that FN3K activity does not protect ␤-cells against the glucotoxic alterations of their survival and function. On the contrary, it may even contribute to the stimulation of islet cell apoptosis by high glucose, maybe through an increase in 3-deoxyglucosone production. However, we have no data to support or infirm this hypothesis at the moment.
As a positive control for islet protein glycation, we cultured the islets in the presence of the more potent glycating agent D-ribose, which leads to the formation of ribulosamines that are the substrate of both FN3K and FN3K-RP (10, 38) . As reported previously in rat ␤-cells, D-ribose markedly reduced the insulin content, preproinsulin gene expression, and glucose stimulation of insulin secretion of mouse islets, whereas it induced apoptosis (20, 30, 41) . These effects were associated with an increase in the mRNA levels of the proapoptotic transcription factor c-Myc and of other oxidative stress response genes, indicating that, as in the rat, ribose impairs mouse ␤-cell function and survival by inducing an oxidative stress. In agreement, NAC markedly reduced ribose-induced islet cell apoptosis. These ribose effects thus resemble those induced by G30 in rat and mouse islets, except for the lack of detectable increase in ␤-cell sensitivity to glucose (23) . They also resembled the effects of overnight exposure to low H 2 O 2 concentration (22, 34) and of a 3-day activation of the proapoptotic Contrasting with its protective effect on islet cell survival during culture in high glucose concentrations, FN3K deficiency increased ribose-induced islet cell apoptosis in a NACsensitive manner. However, this increase (from 8 to 18% apoptotic cells/islet) was too small to result in a stronger reduction of islet insulin content, preproinsulin gene expression, and glucose stimulation of insulin secretion by ribose. Although ribulosamines are also the substrate of FN3K-RP, the higher rate of apoptosis in Fn3k Ϫ/Ϫ islets exposed to ribose may result from the loss of FN3K-catalyzed degradation of ribulosamines with subsequent increase in their level and in oxidative stress. The ϳ50% lower Mt1a mRNA levels in Fn3k Ϫ/Ϫ islets irrespective of the culture condition suggested that these islets may be more sensitive to oxidative stress due to a lower level of antioxidant defense (14, 21, 26) . However, the increase in c-Myc, Hmox1, and Mt1a mRNA levels by ribose was similar in WT and FN3K-deficient islets, suggesting that ribose induced a similar degree of oxidative stress in both types of islets. Because survival of Fn3k Ϫ/Ϫ islets cultured in the presence of ribose and the free radical scavenger NAC was similar to that observed in control islets, it is also possible that a higher level of protein glycation in FN3K-deficient islets may alter the activity of several anti-apoptotic factor(s) involved in cell fate decision or apoptosis execution in face of an increase in oxidative stress. Whatever the mechanism involved, the significant protective role of FN3K against ribose-induced islet cell apoptosis suggests that the enzyme may be more important to protect cells against ribulosamines than previously thought or that it contributes to maintain the cell ability to cope with an increase in oxidative stress. It has indeed been shown in other cell types that protein glycation alters the function of several antioxidant enzymes such as Cu-Zn-superoxide dismutase, catalase, and glutathione reductase (47) .
Earlier studies relying on the protective effects of aminoguanidine and NAC during culture in the presence of high glucose or in rodent models of type 2 diabetes have suggested a role of protein glycation and of the associated increase in oxidative stress in ␤-cell glucotoxicity (24, 35, 39, 40) . However, the correlation between changes in protein glycation and ␤-cell glucotoxic alterations was rather poor in these studies, thereby raising questions about the causal link between both events (24, 39) . It is indeed possible that the beneficial effects of aminoguanidine on ␤-cell glucotoxicity may be unrelated to the reduction in protein glycation but rather depend, like those of NAC, on the reduction of oxidative stress (1, 17) . Despite the lack of effect of FN3K deficiency on ␤-cell function after culture in G10 and G30, our study does not formally exclude the possibility that protein glycation plays a role in ␤-cell glucotoxicity. Thus, it is possible that ␤-cell glucotoxicity depends more strongly on the accumulation of extracellular AGEs than on the alterations of protein function by the "early glycation" products that are the target of FN3K. It is also possible that some of the functional alterations induced by culture in G30 result from the glycation of protein residues that are not accessible to FN3K.
In conclusion, this study clearly demonstrates that, despite its ability to reduce the glycation of intracellular islet proteins, FN3K is neither required for the maintenance of ␤-cell survival and function under control conditions nor involved in protection against ␤-cell glucotoxicity. Therefore, the latter process occurs independently from the associated increase in intracellular fructose-ε-lysines.
